{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:17:00Z","timestamp":1793254620670,"version":"4.5.0"},"reference-count":41,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Neurological manifestations associated with human parvovirus B19 (B19V) infections are rare and varied. Acute encephalitis and encephalopathy are the most common, accounting for 38.8% of all neurological manifestations associated with human B19V. Herein, we report on the clinical features of 13 laboratory-confirmed human cases of B19V-associated encephalitis in Senegal in the framework of a hospital-based surveillance of acute viral encephalitis conducted from 2021 to 2023. Overall, B19V was detected from 13 cerebrospinal fluid samples using specific real time PCR. The mean age was 16.7 years among B19V-positive patients, with a higher prevalence in 0\u20135-year-old children and the sex ratio (male\/female) was 2.25. The B19V-positive patients mainly exhibited hypoleukocytosis, normal glycorrhachia, and normal proteinorrachia in the cerebrospinal fluid. While the main neurological symptoms included meningeal and infectious syndromes. Furthermore, three complete B19V genome sequences were successfully characterized using next-generation sequencing. The newly characterized sequences belonged to the genotype 1a and represent, to date, the first complete B19V genome sequences from Senegal. These sequences could be useful not only in future phylodynamic studies of B19V but also in the development of prevention or treatment countermeasures. Our study is noteworthy for the identification of acute B19V-associated encephalitis in Senegal More investigations on the risk factors associated with B19V transmission in Africa are warranted.<\/jats:p>","DOI":"10.3390\/v17010111","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T05:59:42Z","timestamp":1736920782000},"page":"111","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Clinical Features of Human Parvovirus B19-Associated Encephalitis Identified in the Dakar Region, Senegal, and Viral Genome Characterization"],"prefix":"10.3390","volume":"17","author":[{"given":"Al Ousseynou","family":"Seye","sequence":"first","affiliation":[{"name":"Virology Department, Institut Pasteur de Dakar, 36 Avenue Pasteur, Dakar 200, Senegal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0875-8130","authenticated-orcid":false,"given":"Fatou Kin\u00e9","family":"Top","sequence":"additional","affiliation":[{"name":"Virology Department, Institut Pasteur de Dakar, 36 Avenue Pasteur, Dakar 200, Senegal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maimouna","family":"Mbanne","sequence":"additional","affiliation":[{"name":"Virology Department, Institut Pasteur de Dakar, 36 Avenue Pasteur, Dakar 200, Senegal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5461-5623","authenticated-orcid":false,"given":"Moussa Moise","family":"Diagne","sequence":"additional","affiliation":[{"name":"Virology Department, Institut Pasteur de Dakar, 36 Avenue Pasteur, Dakar 200, Senegal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ousmane","family":"Faye","sequence":"additional","affiliation":[{"name":"Virology Department, Institut Pasteur de Dakar, 36 Avenue Pasteur, Dakar 200, Senegal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amadou Alpha","family":"Sall","sequence":"additional","affiliation":[{"name":"Virology Department, Institut Pasteur de Dakar, 36 Avenue Pasteur, Dakar 200, Senegal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ndongo","family":"Dia","sequence":"additional","affiliation":[{"name":"Virology Department, Institut Pasteur de Dakar, 36 Avenue Pasteur, Dakar 200, Senegal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1107-0859","authenticated-orcid":false,"given":"Jean-Michel","family":"Heraud","sequence":"additional","affiliation":[{"name":"Virology Department, Institut Pasteur de Dakar, 36 Avenue Pasteur, Dakar 200, Senegal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3207-6344","authenticated-orcid":false,"given":"Martin","family":"Faye","sequence":"additional","affiliation":[{"name":"Virology Department, Institut Pasteur de Dakar, 36 Avenue Pasteur, Dakar 200, Senegal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0140-6736(75)91074-0","article-title":"Parvovirus-like particles in human sera","volume":"305","author":"Cossart","year":"1975","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/S0140-6736(83)92152-9","article-title":"Human parvovirus, the cause of erythema infectiosum (fifth disease)?","volume":"1","author":"Anderson","year":"1983","journal-title":"Lancet Lond Engl."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/tmi.13855","article-title":"Prevalence of parvovirus B19 antibodies in pregnant women in northern Benin","volume":"28","author":"Ceriani","year":"2023","journal-title":"Trop. Med. Int. Health"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Manaresi, E., and Gallinella, G. (2019). Advances in the Development of Antiviral Strategies against Parvovirus B19. Viruses, 11.","DOI":"10.3390\/v11070659"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1056\/NEJM199404283301704","article-title":"Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen)","volume":"330","author":"Brown","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Bircher, C., Bieri, J., Assaraf, R., Leisi, R., and Ros, C. (2022). A Conserved Receptor-Binding Domain in the VP1u of Primate Erythroparvoviruses Determines the Marked Tropism for Erythroid Cells. Viruses, 14.","DOI":"10.3390\/v14020420"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1128\/JCM.01201-09","article-title":"Phylogenetic analysis of human parvovirus B19 sequences from eleven different countries confirms the predominance of genotype 1 and suggests the spread of genotype 3b","volume":"47","author":"Mihneva","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"7450","DOI":"10.1073\/pnas.0602259103","article-title":"Bioportfolio: Lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue","volume":"103","author":"Norja","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Bichicchi, F., Guglietta, N., Rocha Alves, A.D., Fasano, E., Manaresi, E., Bua, G., and Gallinella, G. (2023). Next Generation Sequencing for the Analysis of Parvovirus B19 Genomic Diversity. Viruses, 15.","DOI":"10.3390\/v15010217"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12985-021-01569-1","article-title":"Molecular-genetic characterization of human parvovirus B19 prevalent in Kerala State, India","volume":"18","author":"Seetha","year":"2021","journal-title":"Virol. J."},{"key":"ref_11","first-page":"16","article-title":"Prevalence of Human Parvovirus B19 in Neurological Patients: Findings from Region of Western Saudi Arabia","volume":"46","author":"Johargy","year":"2020","journal-title":"Curr. Health Sci. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.5409\/wjcp.v4.i4.126","article-title":"Acute encephalitis and encephalopathy associated with human parvovirus B19 infection in children","volume":"4","author":"Watanabe","year":"2015","journal-title":"World J. Clin. Pediatr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"fmab078","DOI":"10.1093\/tropej\/fmab078","article-title":"Neurological Manifestations Associated with Parvovirus B19 Infection in Immunocompetent Children: Case Series and Systematic Review","volume":"67","author":"Monteiro","year":"2021","journal-title":"J. Trop. Pediatr."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1086\/599042","article-title":"Neurologic Manifestations Associated with Parvovirus B19 Infection","volume":"48","author":"Douvoyianni","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/rmv.1782","article-title":"Neurological aspects of human parvovirus B19 infection: A systematic review","volume":"24","author":"Barah","year":"2014","journal-title":"Rev. Med. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e26324","DOI":"10.1097\/MD.0000000000026324","article-title":"GABAA receptor encephalitis associated with human parvovirus B19 virus infection","volume":"100","author":"Santos","year":"2021","journal-title":"Medicine"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1099\/0022-1317-76-11-2645","article-title":"A new genome type of human parvovirus B19 present in sera of patients with encephalopathy","volume":"76","author":"Umene","year":"1995","journal-title":"J. Gen. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/adc.70.1.71-a","article-title":"Human parvovirus B19 encephalopathy","volume":"70","author":"Watanabe","year":"1994","journal-title":"Arch. Dis. Child."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0140-6736(01)05905-0","article-title":"Association of human parvovirus B19 infection with acute meningoencephalitis","volume":"358","author":"Barah","year":"2001","journal-title":"Lancet Lond Engl."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e02251-21","DOI":"10.1128\/spectrum.02251-21","article-title":"Identification and Genomic Characterization of Parvovirus B19V Genotype 3 Viruses from Cases of Meningoencephalitis in West Bengal, India","volume":"10","author":"Pattabiraman","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12985-023-02079-y","article-title":"Epidemiological characterization of viral etiological agents of the central nervous system infections among hospitalized patients in Egypt between 2016 and 2019","volume":"20","author":"Roshdy","year":"2023","journal-title":"Virol. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"6958","DOI":"10.3390\/cimb45090439","article-title":"Encephalopathy Caused by Human Parvovirus B19 Genotype 1 Associated with Haemophilus influenzae Meningitis in a Newborn","volume":"45","author":"Ferreira","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_23","unstructured":"World Health Organization (2024, June 27). Meningococcal Diseases and Meningitis. Available online: http:\/\/www.emro.who.int\/health-topics\/meningitis\/meningitis.html."},{"key":"ref_24","first-page":"95","article-title":"BioEdit: A user-friendly biological sequence alignment editor and analysis program for Windows 95\/98\/NT","volume":"41","author":"Hall","year":"1999","journal-title":"ScienceOpen"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1093\/nar\/22.22.4673","article-title":"CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice","volume":"22","author":"Thompson","year":"1994","journal-title":"Nucleic Acids Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/molbev\/msw054","article-title":"MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets","volume":"33","author":"Kumar","year":"2016","journal-title":"Mol. Biol. Evol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s13365-020-00885-6","article-title":"Acute viral encephalitis associated with human parvovirus B19 infection: Unexpectedly diagnosed by metagenomic next-generation sequencing","volume":"26","author":"Cao","year":"2020","journal-title":"J. Neurovirol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1128\/CMR.00040-16","article-title":"Human Parvoviruses","volume":"30","author":"Qiu","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e475","DOI":"10.1016\/S1473-3099(24)00373-6","article-title":"Extreme upsurge of parvovirus B19 resulting in severe fetal morbidity and mortality","volume":"24","author":"Russcher","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Tan, L.V., Qui, P.T., Ha, D.Q., Hue, N.B., Bao, L.Q., Cam, B.V., Khanh, T.H., Hien, T.T., Chau, N.V.V., and Tram, T.T. (2010). Viral Etiology of Encephalitis in Children in Southern Vietnam: Results of a One-Year Prospective Descriptive Study. PLoS Negl. Trop. Dis., 4.","DOI":"10.1371\/journal.pntd.0000854"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s13365-017-0568-2","article-title":"Clinical manifestations and treatment outcomes of parvovirus B19 encephalitis in immunocompetent adults","volume":"23","author":"Jun","year":"2017","journal-title":"J. Neurovirol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/jpids\/piz032","article-title":"Prospective Cohort Study of Next-Generation Sequencing as a Diagnostic Modality for Unexplained Encephalitis in Children","volume":"9","author":"Haston","year":"2020","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7150\/ijms.4.105","article-title":"Characterization of erythrovirus B19 genomes isolated in liver tissues from patients with fulminant hepatitis and biliary atresia who underwent liver transplantation","volume":"4","author":"Abe","year":"2007","journal-title":"Int. J. Med. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"110","DOI":"10.7150\/ijms.7.110","article-title":"Parvovirus B19 Genotype Specific Amino Acid Substitution in NS1 Reduces the Protein\u2019s Cytotoxicity in Culture","volume":"7","author":"Kivovich","year":"2010","journal-title":"Int. J. Med. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Ganaie, S.S., and Qiu, J. (2018). Recent Advances in Replication and Infection of Human Parvovirus B19. Front. Cell. Infect. Microbiol., 8.","DOI":"10.3389\/fcimb.2018.00166"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1099\/0022-1317-82-1-191","article-title":"The VP1-unique region of parvovirus B19: Amino acid variability and antigenic stability","volume":"82","author":"Dorsch","year":"2001","journal-title":"J. Gen. Virol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1574-695X.2011.00819.x","article-title":"Human parvovirus B19: General considerations and impact on patients with sickle-cell disease and thalassemia and on blood transfusions","volume":"62","author":"Slavov","year":"2011","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_38","first-page":"2400339","article-title":"An unusual outbreak of parvovirus B19 infections, France, 2023 to 2024","volume":"29","author":"Fouillet","year":"2024","journal-title":"Eurosurveillance"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Kumari, S., Kuruvilla Thomas, R., Sruthi, S., Barani, R., Sangvi, S., Krishnamoorthy, R., and Srikanth, P. (2024). Increased parvovirus B19 seropositivity in healthy blood donors in India. Sci. Rep., 3.","DOI":"10.1038\/s41598-024-68095-2"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Penkert, R.R., Chandramouli, S., Dormitzer, P.R., Settembre, E.C., Sealy, R.E., Wong, S., Young, N.S., Sun, Y., Tang, L., and Cotton, A. (2021). Novel Surrogate Neutralizing Assay Supports Parvovirus B19 Vaccine Development for Children with Sickle Cell Disease. Vaccines, 9.","DOI":"10.3390\/vaccines9080860"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.1016\/j.vaccine.2022.09.009","article-title":"Safety and immunogenicity of parvovirus B19 virus-like particle vaccine lacking phospholipase A2 activity","volume":"40","author":"Suzuki","year":"2022","journal-title":"Vaccine"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/1\/111\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:29:09Z","timestamp":1759919349000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/1\/111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["v17010111"],"URL":"https:\/\/doi.org\/10.3390\/v17010111","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]}}}